ROYAL BANK OF CANADA - RENEO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,000
+150.0%
1,975
+107.5%
0.00%
Q2 2023$6,000952
+1169.3%
0.00%
Q3 2022$075
+400.0%
0.00%
Q2 2022$0
-100.0%
15
-97.2%
0.00%
Q1 2022$2,000
-88.9%
533
-74.8%
0.00%
Q4 2021$18,000
+200.0%
2,115
+173.6%
0.00%
Q3 2021$6,000
+50.0%
773
+79.4%
0.00%
Q2 2021$4,0004310.00%
Other shareholders
RENEO PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 2,409,220$6,384,0009.38%
Abingworth LLP 2,073,957$5,413,0001.73%
Aisling Capital Management LP 886,075$2,348,0001.68%
NEA Management Company, LLC 4,786,921$12,685,0000.65%
Novo Holdings A/S 3,430,377$9,090,0000.45%
Ikarian Capital, LLC 185,597$491,0000.09%
Rock Springs Capital Management LP 1,143,185$3,029,0000.09%
Newtyn Management, LLC 20,983$56,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 70,000$186,0000.00%
Ergoteles LLC 42,400$112,0000.00%
View complete list of RENEO PHARMACEUTICALS INC shareholders